Bayer will acquire German-based HiDoc Technologies in Spring 2025 and commercialize the company’s digital health application, Cara Care, for patients with irritable bowel syndrome (IBS). The app consolidates therapeutic modules that patients can define themselves, focusing on holistic health with options for pharmacological treatment, dietary recommendations and psychological components. Cara Care is the first prescribed digital health application for IBS patients. It helps patients better understand their condition, gain control over their symptoms and achieve a better quality of life. Bayer says the acquisition will enhance its portfolio and set new standards for digital therapeutic solutions.
